<ѻý>VR Headsets in Cath Lab; ICDs & Driving Rules; How Cardiologist Got to Spaceѻý> Recent developments of interest in cardiovascular medicine Oct 01, 2024
<ѻý>Mavacamten Shows Promise in Heart Failure With Normal to Supranormal EFѻý> Cardiac myosin inhibitor linked to improvements in biomarkers in small study Sep 30, 2024
<ѻý>Case Strengthens for Cardiac Myosin Inhibitor in SEQUOIA-HCMѻý> Vast majority of trial participants responded to aficamten Sep 30, 2024
<ѻý>Does Finerenone's Efficacy Diminish if Initiated Late in Heart Failure?ѻý> Benefit of the nonsteroidal MRA otherwise consistent across FINEARTS-HF Sep 29, 2024
<ѻý>Tragus Stimulation for High BP; House Passes HEARTS Act; Risk in Pregnancy Surrogacyѻý> Recent developments of interest in cardiovascular medicine Sep 24, 2024
<ѻý>Reconsider When a Prophylactic ICD Is Needed in Nonischemic Dilated Cardiomyopathyѻý> Meta-analysis holds LGE higher than LVEF in identifying high-risk NIDCM Sep 20, 2024
<ѻý>Lp(a) Cutoffs by Sex; LBBA Pacing Approvals; Loneliness Not to Blame for CVD?ѻý> Recent developments of interest in cardiovascular medicine Sep 17, 2024
<ѻý>Are Regulators the Root of the Problem of Serious Device Recalls?ѻý> Study lays out common gaps in evidence both before and after approval Sep 16, 2024
<ѻý>Defibrillator Positioning; PFA for PVC Ablation; Harvey Weinstein's Heart Surgeryѻý> Recent developments of interest in cardiovascular medicine Sep 10, 2024
<ѻý>Oral Anticoagulation and TAVR Together: A Recipe for Troubleѻý> Continued OAC failed to meet noninferiority in POPular PAUSE TAVI Sep 03, 2024
<ѻý>TAVR's Win in Women; Chest Pressure During Cardioversion; Doc Goes to Spaceѻý> Recent developments of interest in cardiovascular medicine Sep 03, 2024
<ѻý>Nonsteroidal MRA Improves Outcomes in HFpEF, HFmrEFѻý> Randomized trial shows benefits beyond heart failure with low ejection fraction, but not survival Sep 01, 2024
<ѻý>Stenting, TAVR Make Sense Packaged Together for Some Patientsѻý> NOTION-3 trial informs care for those with severe AS and stable CAD Sep 01, 2024
<ѻý>Another Trial Sides With MitraClip for Functional Mitral Regurgitationѻý> RESHAPE-HF2 has provocative implications for a wider pool of TEER candidates Aug 31, 2024
<ѻý>TriClip's 'Soft' Benefits Affirmed in Severe Tricuspid Regurgitationѻý> Randomized trial "highly encouraging" for making patients feel and function better Aug 31, 2024
<ѻý>Pause or Keep RAS Inhibitors Before Surgery? Take Your Pick.ѻý> Either choice is "acceptable" based on randomized study Aug 31, 2024
<ѻý>Amyloidosis Drug Improves Outcomes, Survivalѻý> RNA silencer impresses with results in transthyretin amyloidosis cardiomyopathy Aug 30, 2024
<ѻý>Clot Grabber IFU Recall; Free Cholesterol Tests at CVS; Naloxone for Cardiac Arrestsѻý> Recent developments of interest in cardiovascular medicine Aug 27, 2024
<ѻý>Cardiologist’s Date Rape Verdict; Feds Come Down on DOAC Price; POC Test for HF?ѻý> Recent developments of interest in cardiovascular medicine Aug 20, 2024
<ѻý>Bleeding Better Controlled When Protamine Is Part of TAVR Wrap-Up Routineѻý> ACE-PROTAVI trial tested upfront vs selective use of heparin reversal agent Aug 14, 2024
<ѻý>SGLT2 Hesitance; Furosemide's Indication Grows; Legal Fight Over Entresto Genericѻý> Recent developments of interest in cardiovascular medicine Aug 13, 2024
<ѻý>Sticky Patch Defibrillator; State Telehealth Laws and BP Meds; Ketones and HFpEF?ѻý> Recent developments of interest in cardiovascular medicine Jul 30, 2024
<ѻý>Statin Candidate Pool Shrinks if PREVENT Risk Calculator Is Put to Current Practiceѻý> Fewer people using primary prevention medications expected to result in more CVD Jul 29, 2024
<ѻý>Preeclampsia Blood Marker? Pediatric Cardiac Doc Arrested; Afib-Detecting Ringѻý> Recent developments of interest in cardiovascular medicine Jul 23, 2024
<ѻý>Pay People, and They Will Go to Cardiac Rehabѻý> Financial rewards increase participation in guideline-recommended programs Jul 22, 2024
<ѻý>D.C. Hospital Gets a Wake-Up Call to Chagas Diseaseѻý> Report is part of larger efforts to increase awareness of neglected disease Jul 17, 2024
<ѻý>Industry $$ for New Cardiologists; Strokes After Falls; Self-Cleaning TAVR Valve?ѻý> Recent developments of interest in cardiovascular medicine Jul 16, 2024
<ѻý>This U.S. President Was Dying, but His Doctors Zipped Their Lipsѻý> Eight decades after FDR's decline and death, do White House physicians owe truth to the public? Jul 16, 2024
<ѻý>Diuretics for Ambulatory HF Patients With Volume Overload: Winners & Losersѻý> Three regimens compared head-to-head among abundant choices Jul 10, 2024
<ѻý>Worse-Rated Cardiologists; Afib Pulsed Field Ablation Safety; Healthy Gut Microbe?ѻý> Recent developments of interest in cardiovascular medicine Jul 09, 2024
<ѻý>Potassium Chloride Recall; Exercise vs Valve Disease; Cuffless Continuous BP Monitorѻý> Recent developments of interest in cardiovascular medicine Jul 02, 2024
<ѻý>More Than 1 in 4 Seniors Have Asymptomatic Valve Diseaseѻý> Most cases were mild, and age was a predictor of disease Jun 27, 2024
<ѻý>RNAi Win in ATTR-CM; HF Congestion Monitor Approved; Lp(a) & In-Stent Restenosisѻý> Recent developments of interest in cardiovascular medicine Jun 25, 2024
<ѻý>Major Heart Events Down With Metabolic Surgery for Apnea Patients With Obesityѻý> All-cause mortality also lower compared with nonsurgical controls Jun 24, 2024
<ѻý>Cardiac Shockwave Device Passes Hurdle in Ischemic Cardiomyopathyѻý> Question of clinical benefit beyond LVEF improvement will require larger trials Jun 21, 2024
<ѻý>Cardiology's Private Equity Hot Spots; Statin Overuse; Type B Blood & Heart Injuryѻý> Recent developments of interest in cardiovascular medicine Jun 18, 2024
<ѻý>Amino Acid Infusion Before Cardiac Surgery Reduced Acute Kidney Injuryѻý> The amino acid mixture reduced stage 3 AKI by 44% compared with placebo Jun 12, 2024
<ѻý>Heat Exposure & Heart Stress; 2-Hour POC Troponin Assay; Colchicine After Stroke?ѻý> Recent developments of interest in cardiovascular medicine Jun 11, 2024
<ѻý>Established TAVR Platforms Evolving for Lifetime Managementѻý> New additions to Sapien, Evolut, Navitor lines aim to ensure coronary access Jun 10, 2024
<ѻý>FDA Expands Use of RSV Vaccine to Include More Adultsѻý> Arexvy now approved for people 50 years and older at increased risk of serious outcomes Jun 10, 2024